GGrantIndex
Sort

85,873 grants matching alzheimers

Longitudinal multi-omic biomarkers for neurocognitive decline prior to dementia onset

$2,311,409
Sarah Elizabeth Harris · University Of Edinburgh · U01 · FY2024 · AG

Age-related changes of cognition in health and disease

$2,310,780
Deborah L. Blacker · Massachusetts General Hospital · P01 · FY2006 · AG

Data Science Research

$2,310,322
Mark W Craven · University Of Wisconsin-Madison · U54 · FY2016 · AI

Digital Biomarkers for Vascular Cognitive Decline in Patients with Minor Stroke

$2,310,293
Elisabeth Breese Marsh · Johns Hopkins University · RF1 · FY2022 · AG

Calcium and the Pathophysiology of Neurodegenerative Disorders

$2,310,158
Andrew R Marks · Columbia University Health Sciences · RF1 · FY2020 · NS

Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease

$2,310,151
Lisa L Barnes · Rush University Medical Center · R01 · FY2021 · AG

Engineering Ubiquitin Ligases to Investigate Protein Aggregation and Neurodegener

$2,310,000
Shu-Bing Qian · Cornell University · DP2 · FY2009 · OD

Pulsed laser therapy in an asymptomatic head injury-accelerated Alzheimer's model

$2,309,898
Quanguang Zhang · Augusta University · RF1 · FY2024 · NS

Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric Symptoms

$2,309,451
Michael Alosco · Boston University Medical Campus · RF1 · FY2021 · NS

DYNAMIC NUCLEAR POLARIZATION SOLID STATE NMR SPECTROMETER FOR BIOMOLECULAR STUDIE

$2,309,300
Ann E McDermott · New York Structural Biology Center · S10 · FY2010 · RR

Development of a MT-stabilizing agent for the treatment of tauopathies

$2,309,108
Conor Caffrey · University Of California, San Diego · U01 · FY2024 · AG

Urban Air Pollution and Alzheimer's Disease: Risk, Heterogeneity, and Mechanisms

$2,308,593
Caleb E Finch · University Of Southern California · P01 · FY2020 · AG

Epidemiology of Dementia In An Urban Community

$2,308,243
Richard Mayeux · Columbia University Health Sciences · P01 · FY2007 · AG

Molecular And Pharmacological Studies Of Dopamine Receptors

$2,308,197
David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

Watching Proteins Fold (or Misfold) in vivo with Mass Spectrometry

$2,308,098
Stephen David Fried · Johns Hopkins University · DP2 · FY2020 · GM

Mayo Alzheimer's Disease Research Center

$2,308,035
Ronald C Petersen · Mayo Clinic Rochester · P50 · FY2018 · AG

Gene regulatory mechanisms connecting metabolism and Alzheimer’s Disease

$2,307,286
Chris Gregg · University Of Utah · RF1 · FY2023 · AG

MRI Core

$2,307,265
Clifford Jack · Northern California Institute/Res/Edu · U19 · FY2025 · AG

Neurocomputational mechanisms of learning and decision-making and their disruption in addiction

$2,307,010
Thorsten Kahnt · National Institute On Drug Abuse · ZIA · FY2024 · DA

AGING BRAIN: VASCULATURE, ISCHEMIA, AND BEHAVIOR

$2,305,922
Helena Chang Chui · University Of Southern California · P01 · FY2006 · AG

The Impact of Beta- and Gamma-Synucleins on Alpha-Synuclein's Synaptic Function

$2,305,682
Jacqueline Burre · Weill Medical Coll Of Cornell Univ · RF1 · FY2022 · NS

CAMCI: Advancing the Use of Computerized Screening in Healthcare

$2,305,646
Amy Eschman · Psychology Software Tools, Inc. · RC3 · FY2010 · AG

The VETSA Longitudinal MRI Twin Study of Aging

$2,305,590
William S Kremen · University Of California, San Diego · R01 · FY2016 · AG

ALZHEIMERS DISEASE RESEARCH CENTER

$2,304,872
University Of Washington · P50 · FY2000 · AG

AGING BRAIN: VASCULATURE, ISCHEMIA, AND BEHAVIOR

$2,303,941
University Of Southern California · P01 · FY2005 · AG